Trade

with

Genetic Technologies Ltd
(NASDAQ: GENE)
AdChoices
0.4100
+0.0200
+5.13%
After Hours :
-
-
-

Open

0.4080

Previous Close

0.3900

Volume (Avg)

138.68k (253.74k)

Day's Range

0.3800-0.4270

52Wk Range

0.3200-2.41

Market Cap.

6.59M

Dividend Rate ( Yield )

-

Beta

0.55

Shares Outstanding

19.38M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Diagnostics & Research
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 7.34M

    • Net Income

    • -8.15M

    • Market Cap.

    • 6.59M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -199.22

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 0.55

    • Forward P/E

    • -

    • Price/Sales

    • 1.42

    • Price/Book Value

    • 1.24

    • Price/Cash flow

    • -0.67

      • EBITDA

      • -7.81M

      • Return on Capital %

      • -76.15

      • Return on Equity %

      • -118.15

      • Return on Assets %

      • -76.15

      • Book Value/Share

      • 0.29

      • Shares Outstanding

      • 19.38M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • -

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -49.40

          • 21.91

          • Net Income

            YTD/YTD (last year)

          • -

          • -5.55

          • Net Income

            Q/Q (last year)

          • -

          • 0.44

          • Sales (Revenue)

            5-Year Annual Average

          • -11.84

          • 47.82

          • Net Income

            5-Year Annual Average

          • -

          • 4.98

          • Dividends

            5-Year Annual Average

          • -

          • 5.31

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 65.60

            • 42.70

            • Pre-Tax Margin

            • -200.26

            • 11.63

            • Net Profit Margin

            • -199.22

            • 9.55

            • Average Gross Margin

              5-Year Annual Average

            • 80.30

            • 43.76

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 11.34

            • Average Net Profit Margin

              5-Year Annual Average

            • -63.40

            • 52.13B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.62

              • Current Ratio

              • 1.08

              • 1.23

              • Quick Ratio

              • 0.92

              • 0.76

              • Interest Coverage

              • -13.92

              • 5.98

              • Leverage Ratio

              • 1.48

              • 2.16

              • Book Value/Share

              • 0.33

              • 14.94

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -0.59

                • 32.47

                • P/E Ratio 5-Year High

                • -18.67

                • 325.07

                • P/E Ratio 5-Year Low

                • -0.56

                • 154.73

                • Price/Sales Ratio

                • 1.18

                • 2.26

                • Price/Book Value

                • 1.03

                • 2.95

                • Price/Cash Flow Ratio

                • -0.67

                • 18.55

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -118.15

                    (-54.10)

                  • 9.34

                    (9.80)

                  • Return on Assets %

                    (5-Year Average)

                  • -76.15

                    (-42.90)

                  • 4.63

                    (5.44)

                  • Return on Capital %

                    (5-Year Average)

                  • -69.21

                    (-54.00)

                  • 5.73

                    (6.77)

                  • Income/Employee

                  • -

                  • 17.17k

                  • Inventory Turnover

                  • -

                  • 5.07

                  • Asset Turnover

                  • 0.38

                  • 0.48

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -7.98M
                  Operating Margin
                  -108.70
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -0.67
                  Ownership

                  Institutional Ownership

                  2.04%

                  Top 10 Institutions

                  2.06%

                  Mutual Fund Ownership

                  -

                  Float

                  -

                  5% / Insider Ownership

                  -

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Knight Capital Americas LLC

                  •  

                    25,368

                  • -58.33%

                  • 0.13

                  • Citadel Advisors Llc

                  •  

                    18,496

                  • -60.13%

                  • 0.10

                  • Vassalluzzo Scott J

                  •  

                    13,100

                  • -12.08%

                  • 0.07

                  • ALPINE SECURITIES USVI LLC

                  •  

                    11,100

                  • 0.00%

                  • 0.06

                  • Calvert Asset Management Co Inc

                  •  

                    10,818

                  • +2.54%

                  • 0.05

                  • Tower Research Capital LLC

                  •  

                    4,182

                  • -67.25%

                  • 0.02

                  • Citigroup Inc

                  •  

                    1,538

                  • +206.99%

                  • 0.01

                  • Group One Trading, LP

                  •  

                    998

                  • -33.38%

                  • 0.01

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Diagnostics & Research

                  Type

                  Speculative Growth

                  Style

                  Small Value

                  Genetic Technologies Ltd is incorporated in Australia on January 05, 1987. The Company is a biotechnology company focused on expanding genetic testing business in the Asia-Pacific region and, with the addition of the BREVAGenTM breast cancer risk assessment test, in the U.S.A. and later in Europe. In addition, it is now pursuing commercial opportunities in other areas of activity: out-licensing non-coding patents; and supporting a late-stage research and development project in which it is already involved. The patents in the portfolio includes ntron Sequence Analysis; Genomic Mapping; Perlegen; BREVAGenTM; Laboratory Techniques; Ancestral Haplotypes; Athletic Performance;Nematode Project; and RareCellect Project.

                  Key People

                  Alison J. Mew

                  CEO

                  Mr. Thomas G. Howitt

                  CFO/Secretary

                  Mr. Tommaso Bonvino

                  Director

                  Dr. Malcolm R. Brandon

                  Director

                  Mr. Mervyn Cass

                  Director

                  • Genetic Technologies Ltd

                  • 60-66 Hanover Street

                  • Fitzroy, VIC 3065

                  • AUS.Map

                  • Phone: +61 384127000

                  • Fax: +61 384127040

                  • gtglabs.com

                  Incorporated

                  1987

                  Employees

                  64

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: